|
|
Article: Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business.
- Article from:
- PR Newswire
- Article date:
- September 24, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Seasoned leader brings added expertise to Shire management team
CAMBRIDGE, Mass., and BASINGSTOKE, England, Sept. 24 /PRNewswire-FirstCall/ -- Shire plc , the global specialty biopharmaceutical company, announced today that Sylvie Gregoire has been appointed President of its Human Genetic Therapies (HGT) business, effective immediately. Sylvie brings more than 20 years of management, regulatory affairs, manufacturing and supply chain experience from biotechnology and pharmaceutical companies including Biogen Idec and Merck & Co. Sylvie replaces David Pendergast, former President of HGT, whose retirement was announced in March of this year. To ensure a smooth ...